{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:02:23Z","timestamp":1766012543627,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jns.2020.117015","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T18:33:32Z","timestamp":1594319612000},"page":"117015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study"],"prefix":"10.1016","volume":"416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2216-3973","authenticated-orcid":false,"given":"Carlo","family":"Colosimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay P.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savary","family":"Om","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2020.117015_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/toxins5020249","article-title":"Long-term efficacy and safety of botulinum toxin injections in dystonia","volume":"5","author":"Ramirez-Castaneda","year":"2013","journal-title":"Toxins (Basel)."},{"issue":"3","key":"10.1016\/j.jns.2020.117015_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3111\/13696998.2011.653726","article-title":"Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia","volume":"15","author":"Sethi","year":"2012","journal-title":"J. Med. Econ."},{"issue":"4","key":"10.1016\/j.jns.2020.117015_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12640-012-9314-y","article-title":"Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review","volume":"22","author":"Colosimo","year":"2012","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.jns.2020.117015_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2004.01053.x","article-title":"The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment","volume":"12","author":"Skogseid","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2020.117015_bb0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/174313209X405137","article-title":"A long-term follow-up of botulinum toxin A in cervical dystonia","volume":"31","author":"Mohammadi","year":"2009","journal-title":"Neurol. Res."},{"issue":"2","key":"10.1016\/j.jns.2020.117015_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12640-017-9737-6","article-title":"Long-term Abobotulinumtoxin A treatment of cervical dystonia","volume":"32","author":"Bentivoglio","year":"2017","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.jns.2020.117015_bb0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","article-title":"Long-term botulinum toxin efficacy, safety, and immunogenicity","volume":"20","author":"Mejia","year":"2005","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2020.117015_bb0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/00207454.2012.665971","article-title":"A 17-year experience of abobotulinumtoxina in cervical dystonia","volume":"122","author":"Vivancos-Matellano","year":"2012","journal-title":"Int. J. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2020.117015_bb0045","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00415-019-09349-2","article-title":"Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice","volume":"266","author":"Jochim","year":"2019","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2020.117015_bb0050","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1007\/s00415-019-09527-2","article-title":"Group IICs. How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study","volume":"266","author":"Colosimo","year":"2019","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2020.117015_bb0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00415-017-8698-2","article-title":"INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin","volume":"265","author":"Misra","year":"2018","journal-title":"J. Neurol."},{"author":"International Society for Pharmacoepidemiology (ISPE)","key":"10.1016\/j.jns.2020.117015_bb0060"},{"key":"10.1016\/j.jns.2020.117015_bb0065","series-title":"Therapy with Bofulinum Toxin","article-title":"Clinical assessments of patients with cervical dystonia","author":"Consky","year":"1994"},{"issue":"8501","key":"10.1016\/j.jns.2020.117015_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2020.117015_bb0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.parkreldis.2018.03.002","article-title":"Minimal clinically important change in the Toronto Western spasmodic torticollis rating scale","volume":"52","author":"Espay","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2020.117015_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.07.031","article-title":"Minimal clinically important change in patients with cervical dystonia: results from the CD PROBE study","volume":"405","author":"Dashtipour","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117015_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2019.02.017","article-title":"Effectiveness of botulinum neurotoxin type a injections in naive and previously-treated patients suffering from Torti- or Laterocollis or -caput: results from a German-Austrian open-label prospective post-marketing surveillance study","volume":"399","author":"Jost","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117015_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/toxins10120535","article-title":"AbobotulinumtoxinA (Dysport((R))), OnabotulinumtoxinA (Botox((R))), and IncobotulinumtoxinA (Xeomin((R))) neurotoxin content and potential implications for duration of response in patients","volume":"10","author":"Field","year":"2018","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.jns.2020.117015_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2018.11.100","article-title":"AbobotulinumtoxinA time to retreatment across indications","volume":"156","author":"Gracies","year":"2018","journal-title":"Toxicon."},{"year":"2010","series-title":"For Injection (abobotulinumtoxinA) [Package Insert]","author":"Dysport","key":"10.1016\/j.jns.2020.117015_bb0105"},{"key":"10.1016\/j.jns.2020.117015_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fneur.2017.00035","article-title":"Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin","volume":"8","author":"Contarino","year":"2017","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2020.117015_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00702-012-0872-1","article-title":"AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies","volume":"120","author":"Hauser","year":"2013","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.jns.2020.117015_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000196","article-title":"A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis","volume":"1","author":"Hefter","year":"2011","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jns.2020.117015_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1531-8257(200001)15:1<150::AID-MDS1024>3.0.CO;2-X","article-title":"Patients\u2019 perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A","volume":"15","author":"Brashear","year":"2000","journal-title":"Mov. Disord."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2030352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2030352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:53:29Z","timestamp":1758383609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2030352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":24,"alternative-id":["S0022510X2030352X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117015","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117015"}}